je.st
news
Celgene's Revlimid improves survival in blood cancer patients
2013-07-12 07:30:47| Biotech - Topix.net
Celgene Corp said a late-stage trial of its cancer drug Revlimid met the main goal of improving survival in blood cancer patients.
Tags: blood
cancer
patients
survival
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|